Notably, in line with the event identified in our study, exon 5 of RPS24, an ESRP2-repressed exon, is frequently skipped in prostate tumour tissue [101] and correlates with hypoxia in PCa samples [102], suggesting its AS may serve as a tumour hypoxia marker. Here, ESRP2 is linked to prostate neoplasm.